EP 2289566 A1 20110302 - Medical device comprising a haemostatic agent and haemostatic kit comprising the medical device
Title (en)
Medical device comprising a haemostatic agent and haemostatic kit comprising the medical device
Title (de)
Medizinischen Vorrichtung enthaltend ein hämostatisches Mittel und Kit enthaltend die medizinische Vorrichtung
Title (fr)
Dispositif médical contenant un agent hémostatique et kit contenant le dispositif médical
Publication
Application
Priority
- EP 09159082 A 20021220
- EP 02790278 A 20021220
- DK PA200101941 A 20011221
- EP 02388028 A 20020327
- EP 10178559 A 20021220
Abstract (en)
A haemostatic kit to be used as a medical device provides for a containment unit and a haemostatic agent in said containment unit, said haemostatic agent occupying less than 90% of the volume of the containment unit. This allows for facile and consequently sterile preparation of, for instance, a gelatin paste for use in haemostasis when combined with saline, thrombin or another agent to assist in haemostasis.
IPC 8 full level
A61J 1/05 (2006.01); A61K 9/00 (2006.01); A61L 24/10 (2006.01); A61K 9/10 (2006.01); A61K 38/17 (2006.01); A61L 24/04 (2006.01); A61L 33/12 (2006.01); A61P 7/04 (2006.01); A61P 41/00 (2006.01); B01F 3/12 (2006.01); B01F 13/00 (2006.01); B01F 15/02 (2006.01); B65D 25/08 (2006.01)
CPC (source: EP KR)
A61K 9/00 (2013.01 - KR); A61K 9/009 (2013.01 - EP); A61L 24/043 (2013.01 - EP); A61L 24/10 (2013.01 - KR); A61L 24/102 (2013.01 - EP); A61L 24/104 (2013.01 - EP); A61L 33/12 (2013.01 - KR); A61P 7/04 (2018.01 - EP); A61P 41/00 (2018.01 - EP); B01F 33/00 (2022.01 - KR); A61L 2400/04 (2013.01 - EP)
C-Set (source: EP)
Citation (applicant)
- WO 0128603 A1 20010426 - GENETICS INST [US]
- US 5394886 A 19950307 - NABAI HOSSEIN [US], et al
- US 5645849 A 19970708 - PRUSS THADDEUS P [US], et al
- JP S6221357 A 19870129 - TOSHIBA CORP, et al
- FR 2679772 A1 19930205 - PETERS SA [FR]
- US 6096309 A 20000801 - PRIOR JEFFREY J [US], et al
- US 4515637 A 19850507 - CIOCA GHEORGHE [US]
- US 6045570 A 20000404 - EPSTEIN GORDON H [US], et al
Citation (search report)
- [Y] US 5743312 A 19980428 - PFEIFER THOMAS [DE], et al
- [Y] US 4891359 A 19900102 - SAFERSTEIN LOWELL [US], et al
- [A] FR 2759980 A1 19980828 - BRAS MICHEL [FR]
- [A] WO 9944901 A1 19990910 - SOUTHCORP AUSTRALIA PTY LTD [AU], et al
- [A] US 4522302 A 19850611 - PAIKOFF MYRON [US]
- [AD] US 6045570 A 20000404 - EPSTEIN GORDON H [US], et al
- [AD] FR 2679772 A1 19930205 - PETERS SA [FR]
- [Y] HILL ET AL.: "Use of microfibrillar collagen hemostat (Avitene) and thrombin to achieve hemostasis after median sternotomy", JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, vol. 108, 1994, pages 1151 - 1152, XP002528797
- [L] FUSION MEDICAL TECHNOLOGIES: "FloSeal Matrix Hemostatic Sealant", PRODUCT LEAFLET, July 2001 (2001-07-01), XP002614575
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SI SK TR
Designated extension state (EPC)
AL LT LV MK RO
DOCDB simple family (publication)
WO 03055531 A2 20030710; WO 03055531 A3 20031120; WO 03055531 A8 20040108; AT E448808 T1 20091215; AU 2002367086 A1 20030715; AU 2002367086 B2 20080821; CA 2470684 A1 20030710; CN 1290586 C 20061220; CN 1615160 A 20050511; DE 60234469 D1 20091231; EP 1458425 A2 20040922; EP 1458425 B1 20091118; EP 2078532 A1 20090715; EP 2289566 A1 20110302; HR P20040670 A2 20050630; HU P0402322 A2 20050329; HU P0402322 A3 20120529; JP 2005512734 A 20050512; JP 4527981 B2 20100818; KR 101036696 B1 20110524; KR 20040093673 A 20041106; NO 20042551 L 20040820; PL 371200 A1 20050613
DOCDB simple family (application)
DK 0200898 W 20021220; AT 02790278 T 20021220; AU 2002367086 A 20021220; CA 2470684 A 20021220; CN 02827407 A 20021220; DE 60234469 T 20021220; EP 02790278 A 20021220; EP 09159082 A 20021220; EP 10178559 A 20021220; HR P20040670 A 20040720; HU P0402322 A 20021220; JP 2003556106 A 20021220; KR 20047009885 A 20021220; NO 20042551 A 20040617; PL 37120002 A 20021220